Latest news and press releases about Apollomics, Inc. (APLM): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements.
Price
| Price | $22.11 |
| Market Cap | $49M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -2.92 |
| EV / EBITDA | -6.10 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 288.40% |
| Return on Invested Capital | -1586.77% |
| Return on Assets | -162.93% |
| Gross Margin | 100.00% |
| Operating Margin | -111.45% |
| Net Margin | -128.69% |
Related companies: ADAP · ANL · ATHA · BLRX · GOVX · ICU · LNAI
Explore sector: Healthcare · Biotechnology
More sections of APLM: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks